Learn More
OBJECTIVES This study investigated the benefits of and barriers to user involvement in medical device technology development and evaluation. METHODS A structured review of published literature in peer-reviewed journals was conducted. RESULTS This literature review revealed that the main benefits of user involvement were an increased access to user(More)
PURPOSE Medical device users are one of the principal medical device technology stakeholders. The involvement of users in medical device technology development and assessment is central to meet their needs. This study aims to examine this issue. DESIGN/METHODOLOGY/APPROACH A structured review of the literature published from 1980 to 2005 in peer-reviewed(More)
BACKGROUND Initiatives in the UK to enable patients to access their electronic health records (EHRs) are gathering momentum. All citizens of the European Union should have access to their records by 2015, a target that the UK has endorsed. OBJECTIVES To identify the ways in which patients used their access to their EHRs, what they sought to achieve, and(More)
BACKGROUND Patients on oral anticoagulant therapy (OAT) require regular testing of the prothrombin time (PT) and the international normalised ratio (INR) to monitor their blood coagulation level to avoid complications of either over or under coagulation. PT/INR can be tested by a healthcare professional or by the patient. The latter mode of the testing is(More)
Recent developments in the field of Information Technology (IT), such as integration technologies have promised to bring improvements in the quality of services; however, costs of these technologies are relatively high. Consequently, investment justification for these technologies is one of the many challenges that are faced by managers in healthcare(More)
PURPOSE To identify factors that determine patients' intentions to use point-of-care medical devices, ie, portable coagulometer devices for self-testing of the international normalized ratio (INR) required for ongoing monitoring of blood-coagulation intensity among patients on long-term oral anticoagulation therapy with vitamin K antagonists, eg, warfarin.(More)
  • 1